Roger D. Dansey, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 9,053 shares at $155.69 ($1.4M) on 2020-08-31, disclosed to the SEC on 2020-09-02.
Open-market sale of $1.4M SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.69 | 169 | $26K | 1.9% |
| 2 | $155.69 | 741 | $115K | 8.2% |
| 3 | $155.69 | 741 | $115K | 8.2% |
| 4 | $155.69 | 3,701 | $576K | 40.9% |
| 5 | $155.69 | 3,701 | $576K | 40.9% |
| Total | $155.69 avg | 9,053 |
| $1.4M |
| 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $209K | — | Filing → |
| SGEN | SELL | 2023-04-19 | $2.1M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $137K | — | Filing → |